NIAID

A research team from Boston University has caused controversy for work involving the creation of a hybrid SARS-CoV-2 virus.  Researchers from Boston University’s National Emerging Infectious Diseases Laboratories conducted a study1 to create a chimeric virus which combined the spike protein of the Omicron variant with the initial Wuhan strain of Covid-19.    The idea behind […]

A vaccine for a range of mosquito-borne viruses has received positive results from a Phase I clinical trial.  Scientists at the National Institute of Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC) have developed a vaccine for eastern equine encephalitis virus (EEEV), western equine encephalitis virus (WEEV), and Venezuelan equine encephalitis virus (VEEV).  EEV, […]

New findings by scientists at the National Institutes of Health and their collaborators help explain why some people with COVID-19 develop severe disease. The findings also may provide the first molecular explanation for why more men than women die from COVID-19. The researchers found that more than 10% of people who develop severe COVID-19 have […]